Vir Biotechnology, Inc. — Form D
Vir Biotechnology, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-08. The offering totals $250.0M, of which $250.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-05-08
- Form: D
- Accession: 0001786335-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $250.0M
- Amount sold: $250.0M
- Investors: 1
- Date of first sale: 2020-04-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-366580
Issuer
- Name: Vir Biotechnology, Inc.
- CIK: 0001706431
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 499 ILLINOIS STREET, SAN FRANCISCO, CA, 94158
- Phone: 415-906-4324
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Saira Ramasastry | Director | Raleigh, NC |
| George Scangos | Director | SAN FRANCISCO, CA |
| George Scangos | Executive Officer | SAN FRANCISCO, CA |
| Robert Nelsen | Director | Seattle, WA |
| Kristina Burow | Director | San Diego, CA |
| Kristina Burow | Executive Officer | San Diego, CA |
| Robert More | Director | Carlsbad, CA |
| Dipchand Nishar | Director | Cambridge, MA |
| Robert Perez | Director | Abingdon, Oxfordshire, X0 |
| Jay Parrish | Executive Officer | South San Francisco, CA |
| Philip Sharp | Director | Cambridge, MA |
| Howard Horn | Executive Officer | San Francisco, CA |
| Phillip Pang | Executive Officer | San Francisco, CA |
| Herbert Virgin | Executive Officer | San Francisco, CA |
| Phillip Sharp | Director | San Francisco, CA |
| Michael Kamarck | Executive Officer | San Francisco, CA |
| Vicki Sato | Director | San Francisco, CA |
| Thomas Daniel | Director | San Francisco, CA |
| Alex Bangs | Executive Officer | San Francisco, CA |
| Klaus Frueh | Director | San Francisco, CA |
| Alpna Seth | Executive Officer | San Francisco, CA |
Other filings by this issuer (2)
More